Latest News

Göttingen pharmacologists led by DZHK - scientist Prof. Dr. Ali El - Armouche explore new therapy for heart failure: they activate the heart’s self-protection systems through targeted stimulation.

 

Currently, there is no therapy for myocardial weakness that can stop the...

Read more

Scientific know-how and skills of external partners are sought after in the German Centre for Cardiovascular Research (DZHK). Therefore it is now possible for scientists and institutions which are non-members of the DZHK to offer their specific methods or laboratory procedures...

Read more

In the future, The German Centre for Cardiovascular Research (DZHK) will cooperate with the Competence Network for Congenital Heart Defects and the Competence Network on Atrial Fibrillation. Parts of the scientific infrastructures of the two competence networks are planned to be...

Read more

Atherosclerosis, an inflammatory reaction, is at the root of the most common forms of cardiovascular disease. DZHK researchers from Munich have now identified a microRNA that plays a prominent role in the process, and offers a promising target for new therapies. ...

Read more

First time worldwide: DZHK researcher Prof. Dr. Wolfram-Hubertus Zimmermann and a research team at the University Medical Center Göttingen, Germany, grow heart repair tissue using stem cells from unfertilized oocytes. The concept was first shown in mice and advantages were...

Read more

DZHK researcher Prof. Christian Weber and other researchers from the Ludwig-Maximilians-Universität Munich have, for the first time, elucidated how cells that promote the development of atherosclerosis find their way to the blood vessel wall, where they stimulate the formation of...

Read more

They come from universities, industry and research institutes in the U.S. and Europe and are leading experts in cardiovascular research: The Scientific Advisory Board of the German Centre for Cardiovascular Research (DZHK) convened in the head office in Berlin at the beginning of...

Read more

When should patients with heart failure receive a cardiac support system? Can a drug against hepatitis B also help patients with inflammatory heart disease? Starting in 2013, scientists of the German Centre for Cardiovascular Research (DZHK) want to conduct clinical trials to...

Read more